After announcing he was cancer-free over the summer, Hall of Fame second baseman Ryne Sandberg says disease is back and has ...

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...

Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...

A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...

Former Chicago Cubs player Ryne Sandberg recently took to social media to share a devastating update regarding his health ...

Montell Jordan is advocating for prostate cancer awareness and emphasizing the importance of early detection, particularly ...

Sky Sports is supporting The BIGGER 180 campaign; in the UK, one man dies from prostate cancer every 45 minutes but finding ...

Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival. Discover why CADL stock stays a "Buy" ...

Candel Therapeutics, Inc. (NASDAQ:CADL) announced results from a phase 3 trial of CAN-2409 viral immunotherapy in ...

Ryne Sandberg, the legendary Chicago Cubs second baseman and Baseball Hall of Famer, on Tuesday revealed that his metastatic ...

The new blood-based test — called AR-ctDETECT — is designed to detect and analyze small fragments of tumor-derived DNA in the ...

Famed Chicago Cubs second baseman Ryne Sandberg revealed Tuesday his prostate cancer has returned and “spread to other organs ...